bromouracil has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, PO | 1 |
| Larsen, J | 1 |
| Christiansen, J | 1 |
| Larsen, JK | 1 |
1 other study available for bromouracil and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Flow cytometric measurement of RNA synthesis using bromouridine labelling and bromodeoxyuridine antibodies.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Bromouracil; Flow Cytometry; Fluorescein-5-isothiocyanate | 1993 |